GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Other Gross PPE

Reunion Neuroscience (TSX:REUN) Other Gross PPE : C$0.00 Mil (As of Mar. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Reunion Neuroscience Other Gross PPE?

Reunion Neuroscience's Other Gross PPE for the quarter that ended in Mar. 2023 was C$0.00 Mil.

Reunion Neuroscience's annual Other Gross PPE increased from Mar. 2021 (C$9.79 Mil) to Mar. 2022 (C$34.03 Mil) but then declined from Mar. 2022 (C$34.03 Mil) to Mar. 2023 (C$0.00 Mil).

Reunion Neuroscience Other Gross PPE Historical Data

The historical data trend for Reunion Neuroscience's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Reunion Neuroscience Other Gross PPE Chart

Reunion Neuroscience Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Other Gross PPE
2.11 9.79 34.03 -

Reunion Neuroscience Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.03 - - - -

Reunion Neuroscience Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Reunion Neuroscience (TSX:REUN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Reunion Neuroscience Inc (TSX:REUN) » Definitions » Other Gross PPE
Comparable Companies
TSX:GTMS TSX:NUMI TSXV:SLHG XCNQ:CBDT TSXV:NLH TSXV:PHA TSX:DRDR TSXV:NPTH TSXV:KDA XCNQ:NM HCA SZSE:300015 XTER:FRE SAU:4013 HKSE:06618 XTER:FME BSP:RDOR3 XKLS:5225 ASX:RHC BKK:BDMS
Traded in Other Exchanges
N/A
Address
30 Duncan Street, Lower North Suite, Toronto, ON, CAN, M5V 2C3
Website
https://www.reunionneuro.com
Reunion Neuroscience Inc is engaged in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company's asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment-resistant depression as a potential fast-acting antidepressant with durable efficacy.